|
View: |
Part 1: Document Description
|
|
Citation |
|
|---|---|
|
Title: |
Replication Code for: Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis |
|
Identification Number: |
doi:10.7910/DVN/NAXDC8 |
|
Distributor: |
Harvard Dataverse |
|
Date of Distribution: |
2022-11-21 |
|
Version: |
1 |
|
Bibliographic Citation: |
Ji, Yunan; Einav, Liran; Mahoney, Neale; Finkelstein, Amy, 2022, "Replication Code for: Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis", https://doi.org/10.7910/DVN/NAXDC8, Harvard Dataverse, V1 |
|
Citation |
|
|
Title: |
Replication Code for: Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis |
|
Identification Number: |
doi:10.7910/DVN/NAXDC8 |
|
Authoring Entity: |
Ji, Yunan (McDonough School of Business, Georgetown University) |
|
Einav, Liran (Department of Economics, Stanford University) |
|
|
Mahoney, Neale (Department of Economics, Stanford University) |
|
|
Finkelstein, Amy (Department of Economics, Massachusetts Institute of Technology) |
|
|
Distributor: |
Harvard Dataverse |
|
Access Authority: |
Gubb, Jesse |
|
Depositor: |
Gubb, Jesse |
|
Date of Deposit: |
2022-11-21 |
|
Holdings Information: |
https://doi.org/10.7910/DVN/NAXDC8 |
|
Study Scope |
|
|
Keywords: |
Medicine, Health and Life Sciences, Social Sciences, Health insurance, Medicare, payment reform, randomized controlled trial, field experiment, dialysis, home dialysis, kidney disease, end stage renal disease |
|
Abstract: |
The replication package contains code to replicate tables and figures from "Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis" by Ji, Einav, Mahoney, and Finkelstein (2022). Data is not included in this package as the data must be requested directly from Medicare. Please see the Readme file for additional details. The project evaluates the first year of the End Stage Renal Disease Treatment Choice (ETC) model, a multiyear, mandatory-participation randomized clinical trial of a payment reform, designed and implemented by the US Center for Medicare & Medicaid Innovation (CMMI). The trial found no statistically significantly different rates of home dialysis between treatment and control hospital referral regions during the first year of the program, suggesting that higher incentives may be necessary to change clinician and facility behavior. |
|
Methodology and Processing |
|
|
Sources Statement |
|
|
Data Access |
|
|
Other Study Description Materials |
|
|
Related Publications |
|
|
Citation |
|
|
Identification Number: |
10.1001/jamahealthforum.2022.3503 |
|
Bibliographic Citation: |
Ji Y, Einav L, Mahoney N, Finkelstein A. Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical Trial. JAMA Health Forum. 2022;3(10):e223503. |
|
Label: |
ETC_Replication_Nov2022.zip |
|
Notes: |
application/zip |